Cupps Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2015
Q4 | – | Sell |
-10,390
| Closed | -$834K | – | 182 |
|
2015
Q3 | $834K | Sell |
10,390
-20,798
| -67% | -$1.67M | 0.11% | 122 |
|
2015
Q2 | $3.74M | Buy |
31,188
+1,545
| +5% | +$185K | 0.36% | 91 |
|
2015
Q1 | $3.1M | Buy |
29,643
+4,454
| +18% | +$465K | 0.28% | 98 |
|
2014
Q4 | $2.44M | Sell |
25,189
-82,737
| -77% | -$8.02M | 0.22% | 110 |
|
2014
Q3 | $8.43M | Sell |
107,926
-21,727
| -17% | -$1.7M | 0.78% | 44 |
|
2014
Q2 | $8.19M | Buy |
129,653
+34,806
| +37% | +$2.2M | 0.66% | 57 |
|
2014
Q1 | $6.37M | Sell |
94,847
-7,476
| -7% | -$502K | 0.49% | 72 |
|
2013
Q4 | $6.58M | Buy |
102,323
+344
| +0.3% | +$22.1K | 0.45% | 76 |
|
2013
Q3 | $6.53M | Buy |
+101,979
| New | +$6.53M | 0.42% | 74 |
|